Clinical Trial Update: A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II trial evaluating Carboplatin and Etoposide with or without Obatoclax in extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Obatoclax (obatoclax mesylate)

Snippet

Sponsor: Gemin X | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED